Literature DB >> 25081806

Effects of energy expenditure gene polymorphisms on obesity-related traits in obese children.

Katalin Csernus1, Gábor Pauler2, Éva Erhardt3, Éva Lányi3, Dénes Molnár3.   

Abstract

OBJECTIVE: To assess the frequencies of common polymorphisms of genes associated with energy expenditure among Hungarian obese children and investigate their influences on obesity-related traits and metabolic complications of common childhood obesity. RESEARCH METHODS AND PROCEDURES: In a total of 528 obese children (age 13.2±2.6 years) an oral glucose tolerance test and determination of fasting serum lipid levels were carried out, blood pressure and resting energy expenditure were measured and the children were genotyped for the following gene polymorphisms: Trp64Arg of β3-adrenoreceptor (ADRB3), -3826 A/G of uncoupling protein (UCP)-1, exon 8 45 bp del/ins and -866 G/A of UCP-2, -55 C/T of UCP-3, and Pro12Ala of peroxisome-proliferator activated receptor gamma-2.
RESULTS: Carriers of the ADRB3 Arg64 allele had a significantly higher relative body weight and relative body mass index compared with non-carriers. The UCP-2 exon 8 del/ins polymorphism was associated with higher degree of obesity, insulin resistance, dyslipideamia and lower adjusted metabolic rate. Children with UCP-3 -55 T/T genotype had a significantly lower adjusted metabolic rate than the C allele carriers.
CONCLUSION: We found evidence for associations between common polymorphisms of the ADRB3, the UCP-2 and UCP-3 genes and basic metabolic rate as well as level and metabolic consequences of common obesity among Hungarian school-aged children.
Copyright © 2014 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Childhood obesity; Energy metabolism; Gene polymorphism; Metabolic complications

Mesh:

Year:  2014        PMID: 25081806     DOI: 10.1016/j.orcp.2014.06.001

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  5 in total

1.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

Review 2.  Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.

Authors:  Alessandro Cannavo; Walter J Koch
Journal:  J Cardiovasc Pharmacol       Date:  2017-02       Impact factor: 3.105

3.  Association of gene coding variation and resting metabolic rate in a multi-ethnic sample of children and adults.

Authors:  Maciej S Buchowski; Todd L Edwards; Jacklyn N Hellwege; Digna R Velez Edwards; Sari Acra; Kong Chen
Journal:  BMC Obes       Date:  2017-04-05

4.  Prevalence of uncoupling protein one genetic polymorphisms and their relationship with cardiovascular and metabolic health.

Authors:  Petros C Dinas; Eleni Nintou; Maria Vliora; Anna E Pravednikova; Paraskevi Sakellariou; Agata Witkowicz; Zaur M Kachaev; Victor V Kerchev; Svetlana N Larina; James Cotton; Anna Kowalska; Paraskevi Gkiata; Alexandra Bargiota; Zaruhi A Khachatryan; Anahit A Hovhannisyan; Mariya A Antonosyan; Sona Margaryan; Anna Partyka; Pawel Bogdanski; Monika Szulinska; Matylda Kregielska-Narozna; Rafał Czepczyński; Marek Ruchała; Anna Tomkiewicz; Levon Yepiskoposyan; Lidia Karabon; Yulii Shidlovskii; George S Metsios; Andreas D Flouris
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

5.  Exome Sequencing Identifies A Nonsense Variant in DAO Associated With Reduced Energy Expenditure in American Indians.

Authors:  Paolo Piaggi; Çiğdem Köroğlu; Anup K Nair; Jeff Sutherland; Yunhua L Muller; Pankaj Kumar; Wen-Chi Hsueh; Sayuko Kobes; Alan R Shuldiner; Hye In Kim; Nehal Gosalia; Cristopher V Van Hout; Marcus Jones; William C Knowler; Jonathan Krakoff; Robert L Hanson; Clifton Bogardus; Leslie J Baier
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.